These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Experimental efficacy of anidulafungin against Aspergillus terreus species complex. Sanchis M; Capilla J; Mayayo E; Pastor FJ; Guarro J Med Mycol; 2015 Aug; 53(6):630-5. PubMed ID: 25980004 [TBL] [Abstract][Full Text] [Related]
5. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B. Warn PA; Morrissey G; Morrissey J; Denning DW J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746 [TBL] [Abstract][Full Text] [Related]
6. A nonlethal murine cutaneous model of invasive aspergillosis. Ben-Ami R; Kontoyiannis DP Methods Mol Biol; 2012; 845():569-82. PubMed ID: 22328405 [TBL] [Abstract][Full Text] [Related]
7. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. Hachem R; Gomes MZ; El Helou G; El Zakhem A; Kassis C; Ramos E; Jiang Y; Chaftari AM; Raad II J Antimicrob Chemother; 2014 Nov; 69(11):3148-55. PubMed ID: 25006241 [TBL] [Abstract][Full Text] [Related]
9. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Chamilos G; Kontoyiannis DP Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654 [TBL] [Abstract][Full Text] [Related]
10. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B. Escribano P; Peláez T; Recio S; Bouza E; Guinea J Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity and in vivo efficacy of posaconazole in treatment of murine infections by different isolates of the Aspergillus terreus complex. Salas V; Pastor FJ; Rodríguez MM; Calvo E; Mayayo E; Guarro J Antimicrob Agents Chemother; 2011 Feb; 55(2):676-9. PubMed ID: 21115792 [TBL] [Abstract][Full Text] [Related]
12. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Steinbach WJ; Benjamin DK; Kontoyiannis DP; Perfect JR; Lutsar I; Marr KA; Lionakis MS; Torres HA; Jafri H; Walsh TJ Clin Infect Dis; 2004 Jul; 39(2):192-8. PubMed ID: 15307028 [TBL] [Abstract][Full Text] [Related]
13. Invasive aspergillosis caused by Aspergillus terreus in a non-immunosuppressed patient. Verghese S; Arjundas D; Shakoor TP; Padmaja P; Elizabeth SJ; Maria CF J Assoc Physicians India; 2002 Aug; 50():1086-8. PubMed ID: 12421042 [No Abstract] [Full Text] [Related]
14. In vitro susceptibility testing in Aspergillus species: an update. Lass-Flörl C Future Microbiol; 2010 May; 5(5):789-99. PubMed ID: 20441550 [TBL] [Abstract][Full Text] [Related]
15. Antifungal drug resistance in Aspergillus. Moore CB; Sayers N; Mosquera J; Slaven J; Denning DW J Infect; 2000 Nov; 41(3):203-20. PubMed ID: 11120607 [No Abstract] [Full Text] [Related]
16. Current section and species complex concepts in Aspergillus: recommendations for routine daily practice. Alastruey-Izquierdo A; Mellado E; Cuenca-Estrella M Ann N Y Acad Sci; 2012 Dec; 1273():18-24. PubMed ID: 23230833 [TBL] [Abstract][Full Text] [Related]
17. Aspergillus Biofilms in Human Disease. Williams C; Rajendran R; Ramage G Adv Exp Med Biol; 2016; 931():1-11. PubMed ID: 27271678 [TBL] [Abstract][Full Text] [Related]
18. [Antifungal susceptibilities of Aspergillus spp. strains isolated from invasive aspergillosis cases]. Gürcan S; Tikveşli M; Eryildiz C; Evci C; Ener B Mikrobiyol Bul; 2010 Apr; 44(2):273-8. PubMed ID: 20549962 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp. Martos AI; Martín-Mazuelos E; Romero A; Serrano C; González T; Almeida C; Puche B; Cantón E; Pemán J; Espinel-Ingroff A Diagn Microbiol Infect Dis; 2012 May; 73(1):53-6. PubMed ID: 22480568 [TBL] [Abstract][Full Text] [Related]
20. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates. Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]